Submitted by Anonymous (not verified) on 26 November 2025 - 13:26
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised